Buckingham Research Downgrades Teva Pharma (TEVA) to Neutral

November 30, 2012 1:18 PM EST Send to a Friend
Get Alerts TEVA Hot Sheet
Price: $53.62 +0.04%

Rating Summary:
    17 Buy, 15 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 28 | New: 14
Trade TEVA Now!
Join SI Premium – FREE
Buckingham Research downgraded Teva Pharma (NYSE: TEVA) from Buy to Neutral following today's 2013 guidance update.

For an analyst ratings summary and ratings history on Teva Pharma click here. For more ratings news on Teva Pharma click here.

Shares of Teva Pharma closed at $40.22 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

Buckingham Research

Add Your Comment